Results 101 to 110 of about 3,014 (182)

pH-Responsive Erdafitinib Liposomes with FGFR3 Targeting for Intravesical Bladder Cancer Therapy. [PDF]

Int J Mol Sci
Liang H, Li G, Zhang W, Wang W, Li D, Cheng Y, Song M, Xu X, Lu H.   +8 more
europepmc   +1 more source

FGFR1 Suppresses STING-Mediated Interferon Response in Endocrine Therapy-Resistant Breast Cancer. [PDF]

Cancer Res Commun
Lien TA, Dhakal S, Fosdahl Wium AM, Bergholtz H, Gunesten S, Flatekvål HM, Nebdal D, Vu P, Hurtado A, Norum JH, Sørlie T.   +10 more
europepmc   +1 more source

Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program. [PDF]

Oncologist
O'Hagan A, Siefker-Radtke A, Loriot Y, Deprince K, Crow L, Laron M, Adelman R, Sweiti H, Triantos S.   +8 more
europepmc   +1 more source

A Phase 1, Open-Label, Single-Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR Inhibitor. [PDF]

Clin Pharmacol Drug Dev
Zhu W, Hellemans P, Mitselos A, De Meulder M, Jiao JJ, Tian H.   +5 more
europepmc   +1 more source

Patient-derived organoid-immune co-cultures integrated with multi-omics reveal immunotherapy resistance mechanisms in urothelial carcinoma. [PDF]

Imeta
Jiang S, Song Y, Peng Y, Yan R, Niu Y, Chen B, Lin J, Wu J, Wang S, Du Y, Qin C, Lin Y, Xu T.   +12 more
europepmc   +1 more source

Erdafitinib can combat FGFR-mediated abnormal signaling in cancer

Cancer Research, Statistics, and Treatment, 2023
Sisir Nandi
doaj   +1 more source

A Real-World Study of Patients with FGFR-Altered Advanced Solid Tumors after Exhaustion of Standard-of-Care Treatment. [PDF]

Cancer Res Commun
Demirdjian L, Sweiti H, Harvey R, Standish K, Stone N, Baculea S, Greshock J, Triantos S.   +7 more
europepmc   +1 more source

Erdafitinib-Induced Flexural Calcinosis Cutis in a Pediatric Patient: A Drug-Specific Side-Effect? [PDF]

Pediatr Dermatol
de Benito-Mendieta S, Buendía S, Noguera-Morel L, Colmenero I, Suárez-Traba O, Hernández-Martín Á.   +5 more
europepmc   +1 more source

ChemBang: Expanding the Chemical Space Around Small Molecules. [PDF]

Mol Inform
Montes-Grajales D, Menestrina L, Garcia-Serna R, Mestres J.   +3 more
europepmc   +1 more source

[Everolimus inhibits malignant phenotype of erdafitinib-resistant bladder cancer cells through the p70S6K/PI3K/MAPK signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wu H, Jiang Y, Zhang X, Wang S.
europepmc   +1 more source